Paid Clinical Trials British Columbia
Discover 729 paid clinical trials in British Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Effects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral ChallengesEffects of Inhaled Epinephrine on Systemic Allergic Reactions During Allergy Testing Immunotherapy or Oral Challenges
Sponsor:
Dr. George Luciuk
Location:
Code:
NCT06445374
Conditions
Hypersensitivity
Anaphylaxis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Inhaled Epinephrine
Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple MyelomaFixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06182774
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Daratumumab
Lenalidomide
Dexamethasone
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate CancerA Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Sponsor:
Genentech, Inc.
Location:
Code:
NCT05800665
Conditions
Advanced Prostate Cancer
Metastatic Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RO7656594
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06393374
Conditions
Triple-Negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Sacituzumab tirumotecan
Capecitabine
Cerebral Palsy Hip Outcomes Project - International Multi-centre StudyCerebral Palsy Hip Outcomes Project - International Multi-centre Study
Sponsor:
Holland Bloorview Kids Rehabilitation Hospital
Location:
Code:
NCT01987882
Conditions
Cerebral Palsy
Eligibility Criteria
Sex: All
Age: 2 - 18
Healthy Volunteers: Not accepted
Therapeutic Nutrition With Technology in Primary CareTherapeutic Nutrition With Technology in Primary Care
Sponsor:
University of British Columbia
Location:
Code:
NCT04616482
Conditions
Diet Modification
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Digital therapeutic carbohydrate restriction (TCR) program
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer PatientsA RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Sponsor:
McMaster University
Location:
Code:
NCT03127631
Conditions
Prostate Cancer
Cardiovascular Disease
Eligibility Criteria
Sex: Male
Age: 45+
Healthy Volunteers: Not accepted
Interventions
Nutrition
Exercise
Smoking cessation
Statin (such as Simvastatin, Atorvastatin, Rosuvastatin, Pravastatin)
ACE inhibitor
Study of ALXN2220 Versus Placebo in Adults With ATTR-CMStudy of ALXN2220 Versus Placebo in Adults With ATTR-CM
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT06183931
Conditions
Transthyretin Amyloid Cardiomyopathy
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
ALXN2220
Placebo
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT TrialComparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05773274
Conditions
Metastatic Midgut Neuroendocrine Tumor
Metastatic Midgut Neuroendocrine Tumor G1
Metastatic Midgut Neuroendocrine Tumor G2
Unresectable Midgut Neuroendocrine Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Everolimus
Lutetium Lu 177 Dotatate
Quality-of-Life Assessment